ABCureD presented LPancreas at the Swiss Biotech Day 2026. For more information you can click here.

ABCureD at Voria.gr
ABCureD, a Greek spin-off, says its LPancreas is the world’s first blood test to assess pancreatic damage linked to diabetes
ABCureD presented LPancreas at the Swiss Biotech Day 2026. For more information you can click here.
SHARE ON:

ABCureD, a Greek spin-off, says its LPancreas is the world’s first blood test to assess pancreatic damage linked to diabetes

ABCureD (spinoff of Democritus University of Thrace), was represented by Aikaterini Hatzaki, who presented innovative approaches in the field of medicine and our LPancreas diagnostics kit for diabetes.